Wiedemann M[au] - Search Results

Year	Number of Results
1947	1
1962	1
1967	3
1971	2
1974	1
1975	8
1976	4
1978	1
1979	1
1982	1
1988	2
1989	2
1990	2
1991	1
1992	1
1993	3
1994	2
1995	3
1996	3
1997	5
1998	3
1999	5
2000	1
2001	3
2002	1
2003	2
2004	3
2006	1
2009	3
2010	2
2011	2
2012	1
2013	3
2014	3
2015	6
2016	4
2017	2
2018	3
2019	3
2020	12
2021	5
2022	2
2023	1

1

Immunomodulation and Immune Escape Strategies of Gastrointestinal Helminths and Schistosomes.

Wiedemann M, Voehringer D. Wiedemann M, et al. Front Immunol. 2020 Sep 17;11:572865. doi: 10.3389/fimmu.2020.572865. eCollection 2020. Front Immunol. 2020. PMID: 33042153 Free PMC article. Review.

2

A risk-based approach to managing active pharmaceutical ingredients in manufacturing effluent.

Caldwell DJ, Mertens B, Kappler K, Senac T, Journel R, Wilson P, Meyerhoff RD, Parke NJ, Mastrocco F, Mattson B, Murray-Smith R, Dolan DG, Straub JO, Wiedemann M, Hartmann A, Finan DS. Caldwell DJ, et al. Among authors: wiedemann m. Environ Toxicol Chem. 2016 Apr;35(4):813-22. doi: 10.1002/etc.3163. Epub 2015 Nov 18. Environ Toxicol Chem. 2016. PMID: 26183919 Review.

3

lcsm: An R package and tutorial on latent change score modelling.

Wiedemann M, Thew G, Košir U, Ehlers A. Wiedemann M, et al. Wellcome Open Res. 2022 May 11;7:149. doi: 10.12688/wellcomeopenres.17536.1. eCollection 2022. Wellcome Open Res. 2022. PMID: 36226160 Free PMC article.

4

Healthcare systems--an international review: an overview.

Lameire N, Joffe P, Wiedemann M. Lameire N, et al. Among authors: wiedemann m. Nephrol Dial Transplant. 1999;14 Suppl 6:3-9. doi: 10.1093/ndt/14.suppl_6.3. Nephrol Dial Transplant. 1999. PMID: 10528706 Review.

5

c-Met in chromophobe renal cell carcinoma.

Erlmeier F, Ivanyi P, Hartmann A, Autenrieth M, Wiedemann M, Weichert W, Steffens S. Erlmeier F, et al. Among authors: wiedemann m. Med Oncol. 2017 Feb;34(2):15. doi: 10.1007/s12032-016-0874-1. Epub 2016 Dec 29. Med Oncol. 2017. PMID: 28035577

6

Towards blood flow in the virtual human: efficient self-coupling of HemeLB.

McCullough JWS, Richardson RA, Patronis A, Halver R, Marshall R, Ruefenacht M, Wylie BJN, Odaker T, Wiedemann M, Lloyd B, Neufeld E, Sutmann G, Skjellum A, Kranzlmüller D, Coveney PV. McCullough JWS, et al. Among authors: wiedemann m. Interface Focus. 2021 Feb 6;11(1):20190119. doi: 10.1098/rsfs.2019.0119. Epub 2020 Dec 11. Interface Focus. 2021. PMID: 33335704 Free PMC article.

7

suddengains: An R package to identify sudden gains in longitudinal data.

Wiedemann M, Thew GR, Stott R, Ehlers A. Wiedemann M, et al. PLoS One. 2020 Mar 9;15(3):e0230276. doi: 10.1371/journal.pone.0230276. eCollection 2020. PLoS One. 2020. PMID: 32150589 Free PMC article.

8

Analyzing Longitudinal Data on Singing Voice Parameters of Boys and Girls Aged 8 to 12.5 and Possible Effects of a Music Pedagogical Intervention.

Pieper LH, Körner M, Wiedemann M, Ludwig A, Werner F, Meuret S, Fuchs M. Pieper LH, et al. Among authors: wiedemann m. J Voice. 2022 Jul;36(4):583.e1-583.e16. doi: 10.1016/j.jvoice.2020.07.012. Epub 2020 Aug 22. J Voice. 2022. PMID: 32843260 Clinical Trial.

9

Healthcare systems and end-stage renal disease (ESRD) therapies--an international review: costs and reimbursement/funding of ESRD therapies.

De Vecchi AF, Dratwa M, Wiedemann ME. De Vecchi AF, et al. Among authors: wiedemann me. Nephrol Dial Transplant. 1999;14 Suppl 6:31-41. doi: 10.1093/ndt/14.suppl_6.31. Nephrol Dial Transplant. 1999. PMID: 10528710 Review.

10

PD-L2: A prognostic marker in chromophobe renal cell carcinoma?

Erlmeier F, Weichert W, Autenrieth M, Wiedemann M, Schrader AJ, Hartmann A, Ivanyi P, Steffens S. Erlmeier F, et al. Among authors: wiedemann m. Med Oncol. 2017 May;34(5):71. doi: 10.1007/s12032-017-0926-1. Epub 2017 Mar 28. Med Oncol. 2017. PMID: 28353093

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results